Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.515
+0.1502.80%
Volume:693.85K
Turnover:3.85M
Market Cap:4.49B
PE:-23.61
High:5.800
Open:5.395
Low:5.335
Close:5.365
52wk High:9.850
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:3.50
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.06
PE(LYR):-23.61
PS:4.12

Loading ...

Investor Compensation Cases for Changyao Holdings and Poly Pharmaceutical Set for Court Proceedings

Deep News
·
Jul 02

Huiyu Pharmaceutical Inks Strategic Partnership Deal with Avenacy

Stock News
·
Jul 02

Anthropic Launches Internal Drug Discovery Initiative and AI Research Platform, Focusing on Neglected Diseases

Deep News
·
Jul 01

Anthropic Launches Claude Science to Revolutionize Research and Drug Discovery

Stock News
·
Jul 01

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jun 30

Ocumension Therapeutics Announces CFO Departure and Corporate Secretary Restructure

Bulletin Express
·
Jun 30

Ocumension Therapeutics - Tim Ruan Resigns as CFO, Joint Company Secretary, and Authorized Representative Effective June 30, 2026

THOMSON REUTERS
·
Jun 30

Ocumension details updated board composition and committee assignments

Bulletin Express
·
Jun 30

Ocumension Therapeutics: AGM Approves All Motions; Beibei Zhuang Appointed Independent Director and Audit Chair

Bulletin Express
·
Jun 30

Ocumension Therapeutics Files List of Board, Board Committee Members with Disclosure Responsibilities

Reuters
·
Jun 30

Ocumension Therapeutics Appoints Beibei Zhuang as Independent Director, Audit Committee Chair

Reuters
·
Jun 30

Huiyu Pharmaceutical Subsidiary Receives Clinical Trial Approval for HY-1016 Sustained-Release Injection

Stock News
·
Jun 30

ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases

Stock News
·
Jun 29

Metis TechBio-P Shares Surge Over 10% as AI Drug Discovery Sector Enters Validation Phase

Stock News
·
Jun 29

Huiyu Pharmaceutical Subsidiary Secures International Market Approvals for Multiple Products

Stock News
·
Jun 25

ASCLETIS PHARMA CONDUCTS HK$2.02 MILLION SHARE BUYBACK

Stock News
·
Jun 24

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

ASCLETIS-B Executes Share Buyback on June 22, Spending HK$1.901 Million

Stock News
·
Jun 22

Jianyou Shares' Board Secretary Huang Xiwei: Global Strategy Anchored, Three-Phase Plan Strengthens Full Pharmaceutical Industry Chain

Deep News
·
Jun 22

Hong Kong IPO Prospectus for Zelgen Biopharmaceutical Lapses

Stock News
·
Jun 22